The Department has two Executive agencies.
The Medicines and Healthcare Products Regulatory Agency (MHRA):
The function of MHRA is to enhance and safeguard the health of the public by ensuring that medicines and medical devices work and are acceptably safe. They regulate a wide range of materials from medicines and medical devices to blood and therapeutic products/services that are derived from tissue engineering.
MHRA operates as a trading fund and the costs of medicines regulations are met by fees charged to the pharmaceutical industry. Its income therefore depends on the demand for licenses for medicines. The devices function is funded by the Department.
The net operating cost for 2005-06 was £21.594 million
MHRA annual report
The NHS Purchasing and Supply Agency (PASA):
The role of the agency is to act as a centre of expertise, knowledge and excellence in purchasing and supply matters for the health service.
The net operating cost for 2005-06 was £26.779 million.
PASA annual report